Gabapentin lawsuits are now being filed over dementia, mild cognitive impairment, memory loss, and other serious cognitive problems. New research has raised concerns about a link between these injuries and long-term or repeated gabapentin use.
These cases are still developing, and we are in the early rounds of this. The deeper our lawyers dig into these cases, the more we believe in them.
Now, the litigation is starting to move forward. It seems the center of the litigation will be in state court in Philadelphia. A mass tort program for lawsuits involving gabapentin, sold as Neurontin, and pregabalin, sold as Lyrica, has been established there.











